GLASF vs VRNOF
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLASF is a Sell and VRNOF is a Sell.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GLASF’s FA Score shows that 0 FA rating(s) are green whileVRNOF’s FA Score has 1 green FA rating(s).
- GLASF’s FA Score: 0 green, 5 red.
- VRNOF’s FA Score: 1 green, 4 red.
Price Growth
GLASF (@Pharmaceuticals: Other) experienced а +2.44% price change this week, while VRNOF (@Pharmaceuticals: Other) price change was -12.75% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +56.20%. For the same industry, the average monthly price growth was -6.16%, and the average quarterly price growth was -6.95%.
Reported Earning Dates
VRNOF is expected to report earnings on Apr 03, 2025.
Industries' Descriptions
@Pharmaceuticals: Other (+56.20% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
| GLASF | VRNOF | GLASF / VRNOF | |
| Capitalization | 204M | 1.01B | 20% |
| EBITDA | -24.02M | 36.4M | -66% |
| Gain YTD | 68.922 | -60.268 | -114% |
| P/E Ratio | N/A | 93.46 | - |
| Revenue | 106M | 904M | 12% |
| Total Cash | 13.4M | 95.1M | 14% |
| Total Debt | 73.6M | 502M | 15% |
| RSI ODDS (%) |
| Stochastic ODDS (%) |
| Momentum ODDS (%) |
| MACD ODDS (%) |
| TrendWeek ODDS (%) |
| TrendMonth ODDS (%) |
| Advances ODDS (%) |
| Declines ODDS (%) |
| BollingerBands ODDS (%) |
| Aroon ODDS (%) |
GLASF and
Correlation & Price change
A.I.dvisor indicates that over the last year, GLASF has been loosely correlated with TSNDF. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if GLASF jumps, then TSNDF could also see price increases.
| Ticker / NAME | Correlation To GLASF | 1D Price Change % | ||
|---|---|---|---|---|
| GLASF | 100% | -1.36% | ||
| TSNDF - GLASF | 62% Loosely correlated | -2.00% | ||
| GTBIF - GLASF | 62% Loosely correlated | -4.21% | ||
| TCNNF - GLASF | 58% Loosely correlated | -6.28% | ||
| VRNOF - GLASF | 58% Loosely correlated | -7.29% | ||
| CRLBF - GLASF | 57% Loosely correlated | -2.78% | ||
More | ||||
VRNOF and
Correlation & Price change
A.I.dvisor indicates that over the last year, VRNOF has been closely correlated with GTBIF. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if VRNOF jumps, then GTBIF could also see price increases.
| Ticker / NAME | Correlation To VRNOF | 1D Price Change % | ||
|---|---|---|---|---|
| VRNOF | 100% | -7.29% | ||
| GTBIF - VRNOF | 79% Closely correlated | -4.21% | ||
| CURLF - VRNOF | 77% Closely correlated | -1.79% | ||
| TCNNF - VRNOF | 76% Closely correlated | -6.28% | ||
| TSNDF - VRNOF | 73% Closely correlated | -2.00% | ||
| CRLBF - VRNOF | 72% Closely correlated | -2.78% | ||
More | ||||